Product Program year 2025 Source: CMS Open Payments

Next Gen Ankle

Device Orthopedics/Orthopedic Surgery

Open in the dashboard

General payments

$64,017

46 payments

Research payments

$0

0 payments

Through program year 2025, $64,017 in general payments and $0 in research payments were reported against Next Gen Ankle (Orthopedics/Orthopedic Surgery).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $64,017 46

Breakdown

Who paid General payments · program year 2025
  1. Vilex in Tennessee, Inc. $64,017 46 payments
Top recipients General payments · program year 2025
  1. Jesse Doty Orthopaedic Surgery · Chattanooga, TN $27,089 42% · 13 payments
  2. Taggart Gauvain Foot and Ankle Surgery · Pearland, TX $15,062 24% · 12 payments
  3. Christopher Gross Foot and Ankle Surgery · Charleston, SC $11,904 19% · 9 payments
  4. Paul Fortin Orthopaedic Surgery · Royal Oak, MI $9,963 16% · 12 payments

Each share is of general payments naming this product in 2025.

Specialties paid General payments · program year 2025
  1. Orthopaedic Surgery $37,052 58% · 2 practitioners
  2. Foot and Ankle Surgery Orthopaedic Surgery $26,966 42% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Tennessee $27,089 42% · 1 recipient
  2. Texas $15,062 24% · 1 recipient
  3. North Carolina $11,904 19% · 1 recipient
  4. Michigan $9,963 16% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

46 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record